Related Experiment Video
Updated: Mar 3, 2026

One-step Metabolomics: Carbohydrates, Organic and Amino Acids Quantified in a Single Procedure
Published on: June 25, 2010
Metabolic screening and its impact in children with nonsyndromic intellectual disability
Yasser F Ali1, Salah El-Morshedy1, Riad M Elsayed2
1Department of Pediatrics, Faculty of Medicine, Zagazig University, Zagazig.
Insights
Routine metabolic screening in children with intellectual disability (ID) can identify treatable conditions. Early diagnosis through tests like the ferric chloride test aids in timely intervention, potentially improving outcomes and quality of life for affected children.
Area of Science:
- Pediatric Neurology
- Clinical Genetics
- Metabolic Disorders
Background:
- Intellectual disability (ID) affects a significant number of children, with nonsyndromic cases often presenting diagnostic challenges.
- Identifying underlying metabolic causes is crucial for targeted interventions and improving patient outcomes.
- Routine metabolic screening in this population is not consistently applied, necessitating an evaluation of its utility.
Purpose of the Study:
- To assess the diagnostic value of routine metabolic screening tests in children with nonsyndromic intellectual disability.
- To determine the impact of these tests on identifying treatable conditions and guiding interventions.
- To evaluate the potential of metabolic screening to improve the quality of life for children with ID.
Main Methods:
- A cross-sectional study involving 150 children with nonsyndromic ID and 50 healthy controls.
- Comprehensive assessments included detailed history, family pedigree, clinical examination, and anthropometric measurements.
- Urine metabolic screening utilized ferric chloride test, toluidine blue spot test, and gas chromatography-mass spectrometry.
Main Results:
- Risk factors for ID included consanguineous marriage, advanced parental age, and family history of mental disabilities.
- Metabolic screening revealed positive results in a notable percentage of patients: 35% for ferric chloride test and 9% for GC-MS.
- Only 4.7% of patients tested positive for the toluidine blue spot test, indicating varying sensitivities of different screening methods.
Conclusions:
- Metabolic screening tests are valuable in the diagnostic workup of children with nonsyndromic intellectual disability.
- Positive screening results warrant further specific investigations to confirm diagnoses of treatable metabolic disorders.
- Early identification of treatable conditions through metabolic testing can lead to timely interventions and improved patient management.
Objective:
The objective of this study was to analyze the value of routine metabolic screening tests in children with an intellectual disability (ID) and its impact on improving their outcome and quality of life through appropriate intervention and treatment.
Patients And Methods:
This cross-sectional study was conducted in the Pediatric Neurology Clinic, Al Khafji Joint Operations Hospital, Kingdom of Saudi Arabia. A total of 150 children with nonsyndromic ID (66% males) in the age range of 5-17 years were compared with 50 apparently healthy age- and sex-matched controls. All studied groups were subjected to detailed history taking, family pedigree, thorough clinical examination, anthropometric measurements, routine laboratory investigations and urine metabolic screening tests (ferric chloride test and toluidine blue spot test and gas chromatography-mass spectrometry). Electroencephalography, IQ, psychiatric assessment and chromosomal study were done for the patient group only.
Results:
Positive consanguineous marriage, older maternal or paternal age and family history of mental disabilities in other siblings were considered as risk factors for the development of mental disabilities. History of admission to neonatal intensive care unit was significantly higher among the patient group than among the controls (P<0.05). Metabolic screening tests showed that up to 35% of patients were positive for ferric chloride test, 9% of patients were positive for gas chromatography-mass spectrometry, and only 7 out of 150 (4.7%) patients were toluidine blue test positive.
Conclusion:
Metabolic testing should be considered in the workup of individuals with nonsyndromic ID, which will need further specific investigations to confirm the diagnosis and determine the possible treatable cases.
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
08:30Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
Published on: March 15, 2018
Related Concept Videos
Intellectual Disability
Inborn Errors of Metabolism
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Binet's Contribution to Measures of Intelligence
Environmental Influences on Intelligence